T1	PROC 46 108	Ensayo Clínico en fase IV sobre la seguridad e inmunogenicidad
T2	DISO 144 165	infectadas por el VIH
T3	DISO 196 262	infecciones y lesionas provocadas por el virus del papiloma humano
T4	DISO 274 295	infectadas por el VIH
T5	DISO 330 351	infectadas por el VIH
T6	DISO 390 400	infectadas
#1	AnnotatorNotes T6	C0009450; Communicable Diseases; Disease or Syndrome | C0439663; Infected; Finding | C3714514; Infection; Pathologic Function
T7	ANAT 456 459	ano
#2	AnnotatorNotes T7	C0003461; Anus; Body Part, Organ, or Organ Component | C1278927; Entire anus; Body Part, Organ, or Organ Component
T8	DISO 573 583	infectadas
#3	AnnotatorNotes T8	C0009450; Communicable Diseases; Disease or Syndrome | C0439663; Infected; Finding | C3714514; Infection; Pathologic Function
T9	ANAT 590 601	mucosa anal
T10	ANAT 683 693	canal anal
#4	AnnotatorNotes T10	C0227411; Anal canal; Body Space or Junction | C1280336; Entire anal canal; Body Space or Junction
T11	PROC 706 719	diagnosticara
#5	AnnotatorNotes T11	C0011900; Diagnosis; Diagnostic Procedure
T12	DISO 720 724	HSIL
#6	AnnotatorNotes T12	C0333875; High-Grade Squamous Intraepithelial Lesions; Neoplastic Process
T13	DISO 727 741	carcinoma anal
#7	AnnotatorNotes T13	C0279637; Anal carcinoma; Neoplastic Process
T14	DISO 745 767	Enfermedad oportunista
T15	PROC 819 845	Recuento de linfocitos CD4
#8	AnnotatorNotes T15	C0243009; CD4 Count determination procedure; Laboratory Procedure
T16	ANAT 831 845	linfocitos CD4
T17	ANAT 852 855	cél
#9	AnnotatorNotes T17	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T18	CHEM 115 132	vacuna Gardasil-9
T19	ANAT 445 451	vagina
#10	AnnotatorNotes T19	C0042232; Vagina; Body Part, Organ, or Organ Component | C1278985; Entire vagina; Body Part, Organ, or Organ Component
T20	ANAT 737 741	anal
#11	AnnotatorNotes T20	C0003461; Anus; Body Part, Organ, or Organ Component | C1278927; Entire anus; Body Part, Organ, or Organ Component
T21	DISO 877 884	alergia
#12	AnnotatorNotes T21	C1527304; Allergic Reaction; Pathologic Function
T22	CHEM 888 896	aluminio
#13	AnnotatorNotes T22	C0002367; aluminum; Element, Ion, or Isotope · Pharmacologic Substance
T23	Date 13 17	2019
T24	LIVB 136 143	mujeres
#14	AnnotatorNotes T24	C0043210; Woman; Population Group
T25	LIVB 162 165	VIH
#15	AnnotatorNotes T25	C0019682; HIV; Virus
T26	LIVB 237 262	virus del papiloma humano
#16	AnnotatorNotes T26	C0021344; human papillomavirus; Virus
T27	LIVB 266 273	mujeres
#17	AnnotatorNotes T27	C0043210; Woman; Population Group
T28	LIVB 292 295	VIH
#18	AnnotatorNotes T28	C0019682; HIV; Virus
T29	LIVB 322 329	Mujeres
#19	AnnotatorNotes T29	C0043210; Woman; Population Group
T30	LIVB 348 351	VIH
#20	AnnotatorNotes T30	C0019682; HIV; Virus
T31	Age 356 375	18 años en adelante
T32	Neg_cue 381 383	no
T33	PROC 492 501	genotipos
#21	AnnotatorNotes T33	C1285573; Genotype determination; Laboratory Procedure
T34	LIVB 506 535	Virus Papiloma Humano 16 y 18
#22	AnnotatorNotes T34	C0999806; Human papillomavirus 16; Virus + C0999807; Human papillomavirus 18; Virus
T36	LIVB 565 572	Mujeres
#23	AnnotatorNotes T36	C0043210; Woman; Population Group
T37	PROC 626 635	genotipos
#24	AnnotatorNotes T37	C1285573; Genotype determination; Laboratory Procedure
T38	LIVB 668 675	Mujeres
#25	AnnotatorNotes T38	C0043210; Woman; Population Group
T39	Food 899 907	levadura
#26	AnnotatorNotes T39	C0043392; Yeast, dried; Food
A1	Assertion T6 Negated
A2	Assertion T19 Negated
A3	Assertion T7 Negated
A4	Status T21 History_of
#27	AnnotatorNotes T1	C4054739; Immunogenicity Study; Research Activity + C1705187; Safety Study; Research Activity + C0282462; Phase 4 Clinical Trials; Research Activity
#28	AnnotatorNotes T18	C3864947; Gardasil 9; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor 
#29	AnnotatorNotes T5	C0458074; Human immunodeficiency virus (HIV) status; Finding
#30	AnnotatorNotes T4	C0458074; Human immunodeficiency virus (HIV) status; Finding
#31	AnnotatorNotes T2	C0458074; Human immunodeficiency virus (HIV) status; Finding
#32	AnnotatorNotes T9	C0227414; Anal mucosa; Body Part, Organ, or Organ Component 
#33	AnnotatorNotes T14	C0029118; Opportunistic Infections; Disease or Syndrome 
R1	Experiences Arg1:T24 Arg2:T18	
R2	Experiences Arg1:T24 Arg2:T2	
R3	Causes Arg1:T25 Arg2:T2	
R4	Causes Arg1:T28 Arg2:T4	
R5	Experiences Arg1:T27 Arg2:T4	
R6	Experiences Arg1:T27 Arg2:T3	
R7	Causes Arg1:T26 Arg2:T3	
R8	Experiences Arg1:T29 Arg2:T5	
R9	Causes Arg1:T30 Arg2:T5	
R10	Has_Age Arg1:T29 Arg2:T31	
R11	Negation Arg1:T32 Arg2:T6	
T35	CONC 418 427	inclusión
#34	AnnotatorNotes T35	C1512693; Inclusion; Qualitative Concept
R12	Overlap Arg1:T6 Arg2:T35	
R13	Experiences Arg1:T29 Arg2:T6	
R14	Location_of Arg1:T19 Arg2:T6	
R15	Location_of Arg1:T7 Arg2:T6	
T40	Quantifier_or_Qualifier 464 483	de forma simultánea
#35	AnnotatorNotes T40	C0521115; Simultaneous; Temporal Concept
R16	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T40	
R17	Experiences Arg1:T29 Arg2:T33	
R18	Causes Arg1:T34 Arg2:T6	
R19	Overlap Arg1:T5 Arg2:T6	
R20	Overlap Arg1:T6 Arg2:T33	
R21	Location_of Arg1:T9 Arg2:T8	
T41	Quantifier_or_Qualifier 602 617	simultáneamente
#36	AnnotatorNotes T41	C0521115; Simultaneous; Temporal Concept
R22	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T41	
R23	Experiences Arg1:T36 Arg2:T8	
R24	Experiences Arg1:T36 Arg2:T37	
T42	Quantifier_or_Qualifier 626 663	genotipos 16, 18, 31, 33, 45, 52 y 58
R25	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T42	
R26	Experiences Arg1:T38 Arg2:T12	
R27	Location_of Arg1:T10 Arg2:T12	
R28	Location_of Arg1:T20 Arg2:T13	
R29	Experiences Arg1:T38 Arg2:T13	
T43	CONC 792 801	inclusión
#37	AnnotatorNotes T43	C1512693; Inclusion; Qualitative Concept
R30	Overlap Arg1:T14 Arg2:T43	
T44	Result_or_Value 846 858	< 200 cél/mL
R31	Has_Result_or_Value Arg1:T15 Arg2:T44	
#38	AnnotatorNotes T16	C0039215; CD4 Positive T Lymphocytes; Cell (?)
R32	Causes Arg1:T22 Arg2:T21	
R33	Causes Arg1:T39 Arg2:T21	
R34	Overlap Arg1:T5 Arg2:T33	
A5	Experiencer T38 Patient
A6	Experiencer T36 Patient
A7	Experiencer T24 Patient
A8	Experiencer T27 Patient
A9	Experiencer T29 Patient
